PATENT CLAIM ANALYSIS

Application Number: 16121242
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "282000"]

Abstract:
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.

Claim (Index 43):
The solvent system of  claim 42 , wherein the ratio of emulsifier to oxycodone or pharmaceutically acceptable salt thereof is from about 8:1 to about 1:1 by weight.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.50704
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15284706', '14148909', '14728601', '13349449', '15284711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8012651928986284
- 35 USC 102 Novelty (BERT): 0.5702213710735811
- Combined Prediction Score: 0.7781608107161238
- Mean Citation Score: 436.364156
- Max Citation Score: 445.90518
- Similarity Product: 389.5404291038418

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test